Acro Biomedical (ACBM) Profit After Tax Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 1,617.28% |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 26.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 69.15% |
| Jun 30, 2025 | 84.27% |
| Mar 31, 2025 | 86.21% |
| Dec 31, 2024 | 85.96% |
| Sep 30, 2024 | 84.93% |
| Jun 30, 2024 | 76.63% |
| Mar 31, 2024 | 42.60% |
| Sep 30, 2023 | -179.11% |
| Jun 30, 2023 | -268.81% |
| Mar 31, 2023 | -271.73% |
| Dec 31, 2022 | -272.91% |
| Sep 30, 2022 | -276.51% |
| Jun 30, 2022 | -328.43% |
| Mar 31, 2022 | -184.98% |
| Dec 31, 2021 | -271.71% |
| Sep 30, 2021 | -177.90% |
| Jun 30, 2021 | -106.71% |
| Mar 31, 2021 | -41.89% |
| Sep 30, 2020 | -56.74% |
| Jun 30, 2020 | -74.99% |
| Mar 31, 2020 | 77.73% |
| Dec 31, 2019 | -117.12% |
| Sep 30, 2019 | -130.63% |
| Jun 30, 2019 | -43.71% |
| Mar 31, 2019 | -199.01% |
| Dec 31, 2018 | -75.72% |
| Sep 30, 2018 | 307.68% |